Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology Read more
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data Read more
Depixus Announces Strategic Collaboration With Daiichi Sankyo To Use MAGNA Technology To Accelerate RNA-Targeted Drug Discovery Read more
Japan’s Ministry of Health, Labour and Welfare accepts Arexvy (RSV vaccine) regulatory application to prevent RSV disease in adults aged 50-59 at increased risk Read more
Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies Read more
Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan Read more
Ipsen confirms FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC Read more